SCHEMBL7778142

SCHEMBL7778142

NS(=O)(=O)c1ccc(-c2n[nH]c(CO)c2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.48
PTGS1 P23219 4/20 0.48
TTK P33981 1/20 0.47
CA1 P00915 5/20 0.46
CA2 P00918 5/20 0.46
CA9 Q16790 5/20 0.46
CA12 O43570 4/20 0.46
CA4 P22748 2/20 0.46
CA3 P07451 1/20 0.46
CA6 P23280 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
CA13 Q8N1Q1 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
LRRK2 Q5S007 2/20 0.43
IKBKB O14920 1/20 0.43
CHUK O15111 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779803 0.87 PTGS2 (0.50) PTGS2PTGS1TTKCA1CA2
SCHEMBL7780834 0.87 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL8759350 0.82 PTGS2 (0.44) PTGS2PTGS1TTKCA1CA2
SCHEMBL8629112 0.81 PTGS1 (0.44) PTGS2PTGS1CA1CA2CA9
SCHEMBL7780738 0.80 LRRK2 (0.60) PTGS2PTGS1TTKCA1CA2
SCHEMBL7780596 0.80 MAOA (0.48) PTGS2PTGS1TTKCA1CA2
SCHEMBL7773067 0.80 PTGS2 (0.47) PTGS2PTGS1TTKCA1CA2
SCHEMBL7772912 0.80 CA1 (0.52) PTGS2PTGS1TTKCA1CA2
SCHEMBL7778249 0.79 PTGS2 (0.52) PTGS2PTGS1TTKCA1CA2
SCHEMBL8759299 0.78 LRRK2 (0.55) CA1CA2CA9CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed